Translation

Overview of Translation

Definition

Translation: process of decoding mRNA nucleotide sequence into a polypeptide chain. Occurs in cytoplasm on ribosomes. Final step of gene expression.

Significance

Essential for protein synthesis. Directs amino acid sequence, determines protein structure/function. Links genotype to phenotype.

General Steps

Initiation, elongation, termination. Requires mRNA, ribosomes, tRNA, amino acids, translation factors, energy.

"Translation is the central dogma’s execution phase, where nucleic acid information manifests as functional proteins." -- Alberts et al., Molecular Biology of the Cell

The Genetic Code

Code Characteristics

Triplet codons: 3 nucleotides encode 1 amino acid. Universal in nearly all organisms. Non-overlapping, comma-free.

Degeneracy

Multiple codons code same amino acid. Reduces mutation impact. Example: Leucine has 6 codons.

Start and Stop Codons

Start: AUG (Methionine). Stop: UAA, UAG, UGA (no amino acid, signal termination).

Ribosome Structure and Function

Composition

Two subunits: Large (50S in prokaryotes, 60S in eukaryotes), Small (30S prokaryotes, 40S eukaryotes). Composed of rRNA and proteins.

Functional Sites

Three tRNA binding sites: A (aminoacyl), P (peptidyl), E (exit). Catalyzes peptide bond formation.

Role in Translation

Facilitates mRNA decoding, polypeptide elongation, and translocation. Ensures fidelity and efficiency.

tRNA and Aminoacylation

Structure of tRNA

70-90 nucleotides, cloverleaf secondary structure. Contains anticodon loop pairing with mRNA codon. 3'-end binds amino acid.

Aminoacyl-tRNA Synthetases

Enzymes that charge tRNA with correct amino acid. ATP-dependent activation. Ensures translation accuracy.

Wobble Hypothesis

Flexible base pairing at 3rd codon position. Allows fewer tRNAs to recognize multiple codons.

Initiation of Translation

Prokaryotic Initiation

Small subunit binds Shine-Dalgarno sequence on mRNA. Initiator tRNA (fMet-tRNA) binds start codon. Assembly of initiation complex with IFs and GTP.

Eukaryotic Initiation

Small subunit binds 5' cap of mRNA. Scans for AUG start codon in Kozak consensus sequence. Initiator Met-tRNA joins with initiation factors.

Energy Requirement

GTP hydrolysis drives assembly. Ensures correct positioning and fidelity.

Elongation Process

Codon Recognition

Incoming aminoacyl-tRNA enters A site. Codon-anticodon pairing checked by elongation factors.

Peptide Bond Formation

Peptidyl transferase activity of large subunit catalyzes bond between amino acid in P site and A site.

Translocation

Ribosome shifts 3 nucleotides along mRNA. tRNAs move from A to P to E sites. Elongation factors and GTP involved.

Termination and Release

Stop Codon Recognition

Release factors bind stop codon at A site. No corresponding tRNA exists.

Peptide Release

Peptidyl transferase hydrolyzes bond between polypeptide and tRNA. Polypeptide released.

Ribosome Recycling

Ribosomal subunits, mRNA, tRNA dissociate. Factors and GTP required. Ribosome ready for new cycle.

Post-Translational Modification

Types of Modifications

Phosphorylation, glycosylation, methylation, acetylation, ubiquitination. Alters protein function, localization, stability.

Processing

Signal peptide cleavage, folding by chaperones, disulfide bond formation.

Significance

Regulates activity, targets proteins to organelles, controls degradation.

Regulation of Translation

Initiation Control

Most common regulation point. Initiation factors availability, mRNA secondary structure, upstream ORFs.

Elongation and Termination Control

Less frequent. Elongation factor modifications, ribosome stalling mechanisms.

mRNA Stability and Localization

mRNA half-life affects translation output. Localization controls spatial protein synthesis.

Translation Inhibitors

Antibiotics Targeting Prokaryotic Translation

Chloramphenicol: inhibits peptidyl transferase. Tetracycline: blocks A site. Streptomycin: causes misreading.

Eukaryotic Translation Inhibitors

Cycloheximide: inhibits elongation. Ricin: depurinates rRNA, blocks function.

Research and Therapeutic Use

Inhibitors used to study translation, treat infections, or target cancer cells.

Experimental Techniques

In vitro Translation Assays

Cell-free extracts used to study translation mechanics, measure protein synthesis rates.

Polysome Profiling

Separates ribosome-bound mRNAs by sucrose gradient. Indicates translational efficiency.

Reporter Assays

Fusion of reporter genes to mRNA sequences to monitor translation in vivo.

Clinical Relevance

Genetic Disorders

Mutations in tRNA synthetases or ribosomal proteins cause disease. Examples: Charcot-Marie-Tooth, Diamond-Blackfan anemia.

Antibiotic Resistance

Mutations in ribosomal RNA/proteins confer resistance. Challenge for treatment.

Cancer and Translation

Aberrant translation factor expression promotes tumor growth. Target for therapy.

References

• Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 6th ed. Garland Science; 2014.
• Rodnina MV, Wintermeyer W. Translational control by elongation factor G. Curr Opin Struct Biol. 2011;21(1):123-130.
• Ibba M, Söll D. The renaissance of aminoacyl-tRNA synthesis. EMBO Rep. 2000;1(5):382-387.
• Jackson RJ, Hellen CU, Pestova TV. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol. 2010;11(2):113-127.
• Wilson DN, Nierhaus KH. The weird and wonderful world of bacterial ribosome regulation. Crit Rev Biochem Mol Biol. 2020;55(4):281-296.